Resources - Drug Safety, ISoP official journal

Drug Safety, ISoP official journal

Drug Safety is the premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention. Drug Safety advances the rational use of pharmacotherapy by publishing reviews and original research articles offering guidance for safe and effective drug utilization and prescribing.

Drug Safety offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Drug Safety is published by Springer Nature.

Register for TOC / Alerts
Get the table of contents (TOC) of every new issue published in Drug Safety by signing up for alerts on the journal homepage (on the right inside menu).

Discounted subscription for members

Drug Safety is available online for our members at a discounted price

New horizons for ISoP

A New President’s Vision for International Pharmacovigilance” Article published in Drug Safety (January 2020).

ISoP editorials

ISoP editorials are now a regular feature of our associated journal, Drug Safety. Recent articles include:

Guidelines for publication of adverse drug reaction reports in Drug Safety

Recommendations of a joint ISoP-ISPE group on the guidelines for the submission and publication of adverse drug reaction reports. This paper is published simultaneously in Drug Safety, ISoP’s official journal, and in Pharmacoepidemiology and drug safety, ISPE’s journal.

If ever you submit an adverse drug reaction report to a journal, please respect these recommendations, and cite this paper: Click here for the Guidelines for publication of Adverse Drug Reaction reports

The content of this paper represents ISoP position, and not only its authors’.